Flowable Hemostats Market Set to Reach $1.37 Billion by 2029 with 8% Yearly Growth

What Is the Estimated Market Size and Growth Rate for the Flowable Hemostats Market?
The size of the flowable hemostats market has seen substantial growth in the past few years. The market is projected to increase from $0.95 billion in 2024 to $1.02 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. Factors contributing to the previous growth have been an increase in elective surgeries, a growth in the usage of personalized medicine, a rise in healthcare expenditure, and development of healthcare infrastructure in upcoming markets.

In the coming years, the flowable hemostats market is projected to experience substantial growth, eventually reaching a value of $1.37 billion in 2029. This represents a compound annual growth rate of 7.6%. This predicted growth during the forecast period can be attributed to factors such as the rising number of surgical procedures being performed, an increase in chronic disease prevalence, a growing demand for minimally invasive surgeries, and an aging population requiring surgical intervention. Notable trends during this forecast period include the incorporation of advanced bioengineered materials, the invention of intelligent hemostatic products, the use of robotic-assisted procedures and minimally invasive surgical methods, the pursuit of patient-specific and tailored hemostatic solutions, and sophisticated customization of hemostats.

What Are the Forces Behind the Rapid Growth of the Flowable Hemostats Market?
The surge in surgical operations is predicted to fuel the expansion of the flowable hemostats market in the future. Factors such as an aging population, leading to increased need for age-related surgeries, along with technological advancements making surgeries more safe and accessible, are causing a rise in these operations. Flowable hemostats are particularly valuable during such procedures as they can help control bleeding in hard-to-reach areas where conventional methods might fail. For instance, as stated in a June 2024 report by the International Society of Aesthetic Plastic Surgery (ISAPS), US-based professional non-governmental organization, there was a 3.4% growth in the total number of surgical and non-surgical procedures in 2023, reaching a total of 34.9 million as compared to the previous year. Consequently, the escalating count of surgical procedures is spurring the expansion of the flowable hemostats market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20552&type=smp

Who Are the Dominant Companies Influencing Flowable Hemostats Market Trends?
Major companies operating in the flowable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Baxter International Inc., B Braun Melsungen AG, Becton Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, Mallinckrodt Pharmaceuticals, Integra LifeSciences Holdings Corporation, Gelita Medical GmbH, Ferrosan Medical Devices A/S, Marine Polymer Technologies Inc, Axio Biosolutions Private Limited, Hemostasis LLC, Aegis Lifesciences Private Limited, Medcura Health Inc, Arch Therapeutics Inc., Starch Medical Inc.

Who Are the Dominant Companies Influencing Market Trends?
Significant players in the flowable hemostats market are prioritising the creation of enhanced hemostatic agents, including no-swell technology, to meet the advancing requirements of surgical operations. The no-swell technology is a feature of a hemostatic agent that stops it from expanding by absorbing fluids, making it beneficial for surgeries where swelling can lead to complications. To illustrate, in January 2023, Medcura Inc., a U.S. surgical technology enterprise, received breakthrough device designation from the Food and Drug Administration (FDA) for its LifeGel flowable technology which manages bleeding in surgeries where swelling is not permissible. Medcura's LifeGel is the premier and sole flowable hemostatic gel developed to handle the specific complexities of hemostatic swelling. The absorbent agent, fully hydrated and ready for deployment, does not swell, thereby possibly decreasing swelling-related risks, such as nerve damage and paralysis. LifeGel is not only cost-effective, but it also maintains antimicrobial properties, is relatively clear, and clings to tissues, providing a safer and more efficient method for managing bleeding during intricate surgical operations.

What Are the Different Segmentations in the Flowable Hemostats Market?
The flowable hemostats market covered in this report is segmented -

1) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats
2) By Material: Porcine Gelatin, Bovine Gelatin
3) By Application: General Surgery, Cardiac Surgery, Vascular Surgery, Neuro And Spine Surgery, Orthopedic Surgery, Other Applications
4) By End User: Hospital And Clinics, Ambulatory Surgery Centers

Subsegments:
1) By Active Hemostats: Fibrin Sealants, Thrombin-Based Hemostats, Collagen-Based Hemostats, Biodegradable Polymer Hemostats
2) By Passive Hemostats: Gauze-Based Hemostats, Sponges and Pads, Cellulose-Based Hemostats, Granule-Based Hemostats
3) By Combination Hemostats: Fibrinogen and Thrombin Combination Products, Collagen and Fibrin Combination Products, Synthetic Combination Hemostats, Bioresorbable Combination Hemostats

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/flowable-hemostats-global-market-report

Which Region Is at the Forefront of the Flowable Hemostats Market?
North America was the largest region in the flowable hemostats market in 2024. The regions covered in the flowable hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Flowable Hemostats Global Market Report?

- Market Size Analysis: Analyze the flowable hemostats Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the flowable hemostats market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall flowable hemostats market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the flowable hemostats market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20552

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.